HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Farther Finance Advisors LLC

Farther Finance Advisors LLC grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 26.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,141 shares of the company’s stock after buying an additional 242 shares during the period. Farther Finance Advisors LLC’s holdings in HCA Healthcare were worth $395,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the business. Brighton Jones LLC acquired a new position in shares of HCA Healthcare during the 4th quarter valued at $1,021,000. Principal Securities Inc. increased its holdings in shares of HCA Healthcare by 22.5% in the 4th quarter. Principal Securities Inc. now owns 2,378 shares of the company’s stock valued at $714,000 after purchasing an additional 436 shares during the period. Allworth Financial LP boosted its position in HCA Healthcare by 24.2% during the fourth quarter. Allworth Financial LP now owns 734 shares of the company’s stock valued at $234,000 after purchasing an additional 143 shares during the last quarter. J.W. Cole Advisors Inc. raised its position in HCA Healthcare by 38.5% during the fourth quarter. J.W. Cole Advisors Inc. now owns 1,447 shares of the company’s stock valued at $434,000 after acquiring an additional 402 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock valued at $262,264,000 after purchasing an additional 476,756 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, COO Jon M. Foster sold 15,698 shares of the company’s stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the transaction, the chief operating officer now directly owns 12,646 shares of the company’s stock, valued at approximately $4,670,420.72. This represents a 55.38% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $368.74 on Tuesday. The firm’s 50-day moving average is $359.19 and its 200 day moving average is $333.52. The stock has a market cap of $88.71 billion, a price-to-earnings ratio of 16.78, a PEG ratio of 1.10 and a beta of 1.49. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping the consensus estimate of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter last year, the company earned $5.36 earnings per share. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.78%. HCA Healthcare’s dividend payout ratio is 12.81%.

Analyst Ratings Changes

HCA has been the topic of several recent analyst reports. Guggenheim started coverage on shares of HCA Healthcare in a report on Wednesday, April 9th. They issued a “neutral” rating on the stock. Robert W. Baird restated a “neutral” rating and set a $336.00 target price (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a report on Monday, April 28th. Stephens raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Finally, Morgan Stanley set a $410.00 price objective on shares of HCA Healthcare and gave the stock an “equal weight” rating in a report on Monday, June 9th. Seven equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $392.47.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.